1. SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
- Author
-
Ae Kyung Park, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Nam-Joo Lee, Jeong-Ah Kim, SangHee Woo, Chae young Lee, Jaehee Lee, Sae Jin Oh, JeeEun Rhee, Cheon-Kwon Yoo, and Eun-Jin Kim
- Subjects
Microbiology (medical) ,Epidemiology ,Vaccine Efficacy ,Lee N-J ,et al. SARS-CoV-2 B.1.619 and B.1.620 lineages ,macromolecular substances ,Infectious and parasitic diseases ,RC109-216 ,respiratory infections ,Kim HM ,South Korea ,Republic of Korea ,B.1.620 ,Humans ,viruses ,SARS-CoV-2 ,Kim J-A ,Dispatch ,Lee H ,COVID-19 ,Kim I-H ,2021. Emerg Infect Dis. 2022 Feb [date cited]. https://doi.org/10.3201/eid2802.211653 ,Suggested citation for this article: Park AK ,zoonoses ,Infectious Diseases ,coronavirus disease ,B.1.619 ,Medicine ,SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021 ,severe acute respiratory syndrome coronavirus 2 - Abstract
We report the rapid emergence of severe acute respiratory syndrome coronavirus 2 lineages B.1.619 and B.1.620 in South Korea. The surge in frequency in a relatively short time emphasizes the need for ongoing monitoring for new lineages to track potential increases in transmissibility and disease severity and reductions in vaccine efficacy.
- Published
- 2022